Objective. The aim of this study was to examine the association of CD40 polymorphisms with the risk of SLE in the Korean population.
Introduction
SLE is a complex autoimmune disease that is characterized by production of pathogenic autoantibodies and deposits of immune complexes. The cause of SLE is unknown but strong genetic and environmental components are involved [1] . Recent advances in genotyping technology such as genome-wide association studies (GWAS) have led to the identification of many important risk loci for SLE. These genes, which are generally involved in key pathways of SLE development, are also shared with other autoimmune diseases [2] .
CD40 is a member of the tumour necrosis superfamily and its gene is located on chromosome 20q1213.2 [3] . It has nine exons of between 29 and 412 bp in length [4] . CD40 is expressed on B cells, monocytes, dendritic cells and endothelial cells [5] . It is involved in both humoral and cell-mediated immune responses by binding CD40L, which is expressed on activated T cells [5] . It has a central role in B-cell functions, regulating B-cell proliferation, immunoglobulin switching, antibody secretion, prevention of apoptosis of germinal centre B cells and generation of long-lived memory cells [6] . CD40 knockout mice do not form germinal centres, thus implicating CD40 in B-cell development and maturation [7] . Moreover, immunoglobulin class switching for T-dependent antigens is defective in CD40 knockout mice [7] . Crow and Kirou [8] showed that prolonged expression of CD40L and high levels of circulating CD40L activate autoimmune B cells and initiate autoantibody formation in SLE.
CD40 polymorphism is known to be associated with autoimmune diseases such as Graves' disease and giant cell arteritis [9, 10] . Meta-analysis of two published GWAS of RA revealed that CD40 is a novel RA-susceptibility gene [11] , and a recent study showed that RA and SLE have shared susceptibility genes such as STAT4 [1214] , PTPN22 [12] , TNFAIP3 [12] and TRAF [15, 16] . However, the association between CD40 and SLE is still not understood. Based on these observations we have investigated whether SNPs in CD40 influence susceptibility to SLE and its symptoms.
Materials and methods

Patients
A total of 601 Korean patients with SLE and 984 ethnically matched healthy Korean controls were recruited in Hanyang University Hospital for Rheumatic Diseases, Seoul, Korea. The patients with SLE were selected from the BAE Lupus Cohort and fulfilled the 1997 ACR revised criteria for the classification of SLE [12] . The mean (S.D.) age of the SLE patients was 32.36 (11.13) years, and they comprised 6.16% males and 93.84% females. Of these patients, 43.59% had renal disorders and 61.23% had non-erosive arthritis during any interval of observation. The clinical characteristics of the patients with SLE are shown in Table 1 . Written informed consent was obtained from each subject. The study was approved by the Institutional Review Board of Hanyang University Hospital.
SNP selection and genotyping
We selected seven SNPs in the CD40 gene (rs1800686, rs1883832, rs4810485, rs1535045, rs73115010, rs6074028 and rs3765456) based on previous results for the CD40 gene in the Korean population [4] . LD relations among the screened SNPs were evaluated using Haploview software (Cambridge, MA, USA; http://www. broad.mit.edu/mpg/haploview). SNP genotyping was performed using the TaqMan assay [17] on an ABI prism 7900HT sequence detection system (Applied Biosystems, CA, USA), and information on the genotyping probes is given in supplementary Table S1 (available as supplementary data at Rheumatology Online). The quality of the genotyped data was assessed by duplicate DNA checking (n = 30; rate of concordance in duplicates >99.8%). Using the PHASE algorithm ver. 2.0 software [18] , haplotypes were inferred from the successfully genotyped SNPs, and those with frequencies of >0.05 were included in the association analyses.
Statistical analyses
LD between all pairs of bi-allelic loci were determined using Lewontin's D 0 (jD 0 j), and LD coefficients. The r 2 -values were examined using the Haploview algorithm [19] . To determine the associations of CD40 SNPs and haplotypes between SLE patients and normal subjects, as well as among SLE patients, odds ratios (ORs) (95% CIs) and the corresponding P-values were calculated using logistic analysis, controlling for age (continuous variable), gender (male = 0, female = 1) and/or disease duration (continuous variable) as covariates. Data were managed and analysed using Statistical Analysis System (SAS) version 9.1 (SAS Inc., Cary, NC, USA). To achieve optimal correction for multiple testing of markers representing SNPs in LD with each other, the effective number of independent marker loci (4.107) was calculated using SNPSpD (http://genepi. qimr.edu.au/general/daleN/SNPSpD/), a program that is based on the spectral decomposition of matrices of pair-wise LD between markers [20, 21] . The resulting number of independent marker loci of CD40 (4.107) was applied for correction of CD40 SNPs and haplotypes. Statistical power of single associations was calculated with a false-positive rate of 5%, disease lifetime prevalence of 0.04%, given minor allele frequencies and sample sizes and assuming a relative risk of 1.3, using PGA (Power for Genetic Association Analyses) [22] .
Results
Polymorphisms and analysis
The frequencies of allele and genotype for CD40 polymorphisms are listed in supplementary Tables S1 and S2 (available as supplementary data at Rheumatology Online): one (rs1800686) is in the promoter, one (rs1883832) in the 5 0 -untranslated region (5'-UTR) and five (rs4810485, rs1535045, rs73115010, rs6074028 and rs3765456) in introns. These seven polymorphisms were present at relatively high frequencies (0.2770.358) in our Korean cohort, and no significant deviations from HardyWeinberg equilibrium were observed in any polymorphism. There were two sets of tight linkage: r 2 = 0.97 between rs1800686 and rs1535045, and r 2 = 0.97 between rs1883832 and rs4810485 (Fig. 1b) . Haplotype construction showed that three major haplotypes account for 91.5% of the 18 haplotypes observed (Fig. 1a) . Haplotypes with frequencies of <5% were excluded from further statistical analysis.
CD40 polymorphisms and SLE susceptibility
We assessed the associations of these seven SNPs with SLE susceptibility using logistic regression model controlling for age and sex as covariates. In casecontrol analysis, rs1883832, rs4810485 and rs3765456 were associated with SLE susceptibility, but the association of rs3765456 was only retained in the dominant model after correction (OR = 1.34, P = 0.007, P corr = 0.03, statistical power = 89.33%; Table 2 ). Similarly, for the rs3765456 polymorphism, we observed a higher prevalence of A alleles (OR = 1.18, P = 0.04) in SLE patients than in controls. The frequencies of rs1883832 and rs4810485 in the dominant model were higher in SLE patients than controls, suggesting that no statistically significant differences remained after correction, despite their contribution to an increased risk of SLE. 
CD40 polymorphisms and SLE phenotypes
We subsequently investigated whether CD40 polymorphisms could predispose to any particular manifestations of SLE. The difference in genotype distribution between patients with and without the various ACR clinical SLE features was analysed using logistic regression using age, sex and disease duration as covariates among lupus patients. Significant associations with the increased risk of arthritis were found in rs1883832, rs1535045, rs73115010 and rs6074028 in the recessive model; however, the associations of rs73115010 and rs6074028 were only retained after correction (OR = 2.81 and 2.76, P corr = 0.009 and 0.02, respectively; Table 3 ). In subsequent analysis with the risk of renal disorder, rs1883832, rs481085 and rs3765456 were marginally associated with decreased risk of nephritis, although the signals disappeared after correction ( Table 3) .
Associations of CD40 haplotypes with susceptibility to SLE and SLE phenotypes Three common haplotypes (ht1, ht2 and ht3) were analysed for SLE susceptibility and risk of SLE-related phenotypes using a logistic regression model controlling for age, sex and disease duration as covariates. Although CD40-ht2 (GTTCTAA) showed marginal association with SLE susceptibility in the dominant model, the association disappeared after correction (Table 4 ). In subgroup analysis among lupus patients, CD40-ht2 (GTTCTAA) had a protective effect on LN in the recessive model after correction (OR = 0.47, P = 0.01, P corr = 0.05; Table 4 ), whereas CD40-ht3 (ACGTCGG) was associated with increased risk of arthritis in the recessive model (OR = 2.46, P = 0.01, P corr = 0.05; Table 4 ).
Discussion
The CD40CD40L interaction is a key factor in the pathogenesis of SLE. In SLE, the regulation of CD40L expression is impaired and results in increased or prolonged expression [8] . This contributes to B-cell activation, hypergammaglobulinaemia and autoantibody production. Moreover, the CD40CD40L interaction may contribute to complications of SLE such as nephritis, atherosclerosis and thrombosis via renal epithelial cells, blood vessel endothelial cells and smooth muscle cells. The polymorphisms of the CD40 gene have complex effects on the efficiency of transcription and translation of CD40 protein. For example, individuals with the rs1883832 TT genotype have lower circulating soluble CD40 levels in lymphoma [23] and the C allele of the CD40 Kozak SNP could predispose to disease by increasing the efficiency of translation of CD40 mRNA in Graves' disease [9] . Moreover, SNP rs4810485 in CD40 is correlated with CD40 expression in patients with SLE [24] . Based on these biological findings we have evaluated the associations of CD40 polymorphisms with SLE. There have been several association studies performed for CD40 in SLE. Chadha et al. [25] studied the association of CD40 with SLE in European Caucasians using C/C, C/R and R/R: common homozygote, heterozygote and rare homozygote, respectively. P corr : corrected P-value in multiple testing. Logistic regression models were used for calculating ORs (95% CIs) and corresponding P-values for all the SNP sites and haplotypes. The results of co-dominant, dominant and recessive models are given. Age (continuous value), sex (male = 0, female = 1) and disease duration (years) were adjusted by inclusion in the logistic analysis as covariates. Diag: diagnosis. *Significant values.
www.rheumatology.oxfordjournals.org 627 CD40 polymorphism in SLE family-based tests of association but did not observe any association with SLE for CD40 polymorphisms. In GWAS, 20q11-13, a region linked with SLE, was studied to search for a marker for an SLE susceptibility gene in European Caucasians, Mexican Americans and African Americans. Moser et al. [26] studied 94 multiplex SLE families and identified the chromosome 20q13 potential susceptibility loci in the combined pedigree collection. However, after stratification by race, there was no strong association between this region of the genome and SLE. Shai et al. [27] also showed that there was no significant association with SLE for chromosome 20q13 in either Mexican American or Caucasian SLE subjects. Recently, however, Vazgiourakis et al. [24] showed that rs4810485 G/T and T/T genotypes in CD40 were susceptibility genotypes for SLE in Greeks and Turks [24] . They suggested the possibility of association of CD40 polymorphisms with SLE susceptibility. rs4810485 was confirmed as an RA risk variant in a European population [11] but not in a Korean one [28] . We demonstrated above that rs4810485 was not associated with the risk of SLE in the dominant model after correction. Instead, another SNP, rs3765456, was significantly associated with an increased risk of SLE in Korean patients in the dominant model. This indicates that the genetic risk alleles for SLE may differ between ethnic groups and may need to be validated in independent populations. After identifying an SLE susceptibility genotype, we analysed the associations between CD40 SNPs and various clinical manifestations of SLE. Our analysis revealed that CD40 polymorphism was associated with arthritis. rs73115010 and the rs6074028 showed increased risk of arthritis in the recessive model. One study showed that fibroblast expression of CD40 and CD40L is up-regulated by cytokines such as IFN-g and IL-6 [29] . Finally, the CD40CD40L interaction up-regulates intercellular adhesion molecule and vascular cell adhesion molecule-1 levels and augments synovial inflammation. Thus, these genotypes may be responsible for the development of inflammatory arthritis in our population. Functional analysis is needed to confirm the association of CD40 expression level on fibroblasts with specific CD40 SNPs.
We also investigated the association of SNPs with nephritis. There have been attempts to evaluate the role of CD40CD40L in regulating inflammation in LN. van Kooten et al. [30] demonstrated that CD40 expression was elevated in cultured proximal tubular epithelial cells from lupus patients, and that cross-linking the CD40 receptor on these cultured proximal tubular cell resulted in strong up-regulation of chemokines and cytokines. They suggested that the CD40CD40L interaction in proximal tubules was an important element in the causation of LN. Yellin et al. [31] reported that glomerular and tubular CD40 expression was markedly up-regulated in class III and class IV lupus GN, especially in proximal and distal tubules and interstitial mononuclear cells. Mohan et al. [32] also suggested that interaction between CD40 and its ligand gp39 was a key factor in GN and they showed that blocking this interaction ameliorated severe GN. However, our analysis revealed that the CD40 SNP was not associated with renal disorders. Thus, we further examined the association between clinical features including LN and haplotype.
In the haplotype analysis, the ht2 (GTTCTAA) had a protective effect on LN in the recessive model, whereas ht3 was an increased risk of the arthritis in the recessive model, even after correcting the P-value for multiple testing (P corr = 0.05 and P corr = 0.009, respectively). This effect of ht2 might come from rs1883832, rs4810485 and rs3765456, which were almost tagging ht2. Also, the association of ht3 might result from the genetic effect of rs73115010, which almost had tagging status. These haplotypes may be involved in the pathogenesis of clinical features. Based on previous studies, it is possible that the CD40-ht2 polymorphism in the recessive model alters the expression of CD40 on renal proximal tubules, decreases renal inflammation and protects against LN. Thus, CD40-ht2 may lead to a good prognosis in LN, although the sample size is relatively small and the statistical power of subsequent analysis of renal disorder is in the range 48.0055.33. However, the result of subgroup analysis should be interpreted with caution due to the low power.
In summary, we have shown that certain CD40 gene polymorphisms are possible risk factors for SLE, especially rs3765456 in the dominant model. Moreover, CD40 polymorphisms are also associated with the clinical manifestations of SLE although the statistical power was low in subgroup analysis. Replication in a larger sample and in different ethnic groups is needed.
Rheumatology key messages
. SNP rs3765456 is a possible risk factor for SLE development among Koreans. . CD40 polymorphisms are associated with symptoms of SLE, especially nephritis and arthritis.
